ReviewFrontiers in immunology2026

Obinutuzumab for the treatment of podocytopathy with concurrent suspected but unconfirmed B-cell lymphoproliferative disorder: a case report and literature review.

Yong-Zhe Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.